Explore the latest in allergy and clinical immunology, including asthma, food allergy, immunotherapy, atopic dermatitis, and more.
This study evaluates the interrater agreement and reliability of skin-specific and range of motion variables of the 2014 National Institutes of Health response criteria for patients with chronic graft-vs-host disease as well as a skin sclerosis grading scale.
This JAMA Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic esophagitis.
This retrospective study evaluated 11 patients who underwent cardiac implant patch testing to assess the frequency of allergic reaction.
This Medical Letter review summarizes the use of Symjepi, a single-dose, prefilled epinephrine syringe for manual infection during emergency treatment of anaphylaxis.
This study reports the development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
This cohort study examines the use of screening in Chinese patients with leprosy before dapsone treatment for the HLA-B*13:01 allele associated with dapsone hypersensitivity syndrome.
This meta-analysis evaluated the efficacy and safety of topical phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis.
This Medical News feature discusses findings from a recent study on the prevalence of adult-onset food allergies and the potential reasons behind them.
A man presents with bullae and vesicles on his face, neck, and hands with irregular hyperplasia and spongiosis of the epidermis, among other histological abnormalities. What is your diagnosis?
This Medical News & Perspectives article describes a report showing that the prevalence of atopic eczema rebounds in older adults.
This randomized clinical trial compares the efficacy and safety of epicutaneous immunotherapy with a peanut patch vs placebo among peanut-allergic children.
This cross-sectional study examines gender equity in the presidential leadership of medical specialty societies over a 10-year period.
This survival and cost-effectiveness analysis study uses survival curves from the ZUMA-1 trial (Safety and Efficacy of KTE-C19 in Adults With Refractory Aggressive Non-Hodgkin Lymphoma) to estimate long-term survival and cost-effectiveness associated with axicabtagene ciloleucel, a chimeric antigen receptor T-cell therapy, vs chemotherapy for treatment of relapsed or refractory B-cell lymphoma in adults.
This systematic review and meta-analysis synthesizes the available literature to evaluate the association between atopic dermatitis and suicidality.
This analysis uses Markov simulations of the Chicago Public Schools system to define value-based strategies and cost-effectiveness of undesignated school stock epinephrine programs based on analysis of children with peanut allergies.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: